Abstract:

〔Abstract〕 Objective： To analyze the utilization of antitumor drug in patients with lung cancer in the First Affiliated Hospital of Dali University and evaluate the rationality of drug use. Methods： A total of 172 inpatients diagnosed with advanced lung cancer in this hospital in 2020 were selected as the research objects to retrospectively analyze the rationality of the therapeutic regimen and medication safety for lung cancer patients. Results： The therapeutic regimens for patients with lung cancer were reasonable， and most of them were platinum-containing dual-drug regimen. Irrational drug use mainly focused on the process of drug use， including inappropriate usage and dosage， inappropriate pretreatment and off-label drug use. The main adverse reaction after drug treatment was myelosuppression. Conclusion： There are still irrational situations in the chemotherapy process for the patients with lung cancer. Medical institutions should pay attention to the rationality evaluation of antitumor drug， and further promote the standardized and rational use of drugs in clinical practice.

Key words:

"> font-size:10.5pt, ">lung cancer, antitumor drug, therapeutic regimen, adverse reaction